Full-Time

Process Development Associate

Team: Profiling Development

Posted on 9/16/2025

Nomic

Nomic

51-200 employees

high-throughput proteomics platform employing nELISA

No salary listed

Montreal, QC, Canada

In Person

Category
Biology & Biotech (2)
,
Requirements
  • B.S. or M.Sc in a bioengineering-related field or equivalent, with 1–3 years of relevant hands-on lab experience (academic or industry).
  • Familiarity with techniques such as ELISA, flow cytometry, bead-based assays, bio-conjugation & purification, spectroscopy, microscopy, PCR, or cell culture.
  • Strong communication skills and ability to document work clearly and completely.
  • Comfortable working independently and collaboratively in a fast-paced environment.
  • For candidates in Quebec, knowledge of English is required due to regular communication with colleagues, clients, and partners across Canada and other countries.
Responsibilities
  • Run and Validate Profiling Workflows – Perform hands-on experiments to support the validation of new workflows and protocol updates. You’ll follow SOPs, generate and document data, and work closely with scientists and engineers to ensure consistent performance across our high-throughput protein profiling platform.
  • Assist Troubleshooting and Continuous Improvement – Help investigate issues when they arise by supporting root cause analysis and experimental follow-up. You’ll contribute to testing workflow changes aimed at improving throughput, data quality, and robustness.
  • Support Lab Operations and Documentation – Take part in daily lab activities such as reagent preparation, instrument upkeep, and consumables tracking. You’ll contribute to maintaining well-organized records and ensure traceability through our LIMS and digital tools.
  • Help Deploy and Train – Assist in transferring validated protocols into production by participating in pilot runs, updating documentation, and supporting training efforts for operations teams.
Desired Qualifications
  • Bonus: Experience with liquid handler automation, conjugation chemistry, or multi-color flow cytometry.
  • Bonus: Experience handling diverse sample types or working with variable biological matrices.

Nplex Biosciences develops proteomics tools using nanotechnology, including the nELISA platform for high-throughput protein measurement. The platform uses DNA nanotechnology to identify proteins on micron-sized beads, enabling miniaturized, highly parallel immunoassays. It differentiates itself by combining DNA-based protein identification with bead-based assays and a scalable, cost-efficient workflow that lowers the cost of antibody-based proteomics. Its goal is to provide a reliable, scalable proteomics platform that supports drug discovery, biomarker discovery, and personalized medicine.

Company Size

51-200

Company Stage

Series B

Total Funding

$60.1M

Headquarters

Montreal, Canada

Founded

2017

Simplify Jobs

Simplify's Take

What believers are saying

  • Omni 1000 democratizes proteome-wide profiling for drug discovery and biomarker validation.[5]
  • $42M Series B September 2024 funds commercial expansion amid rising demand.[5]
  • Context-specific ~300-protein panels enable targeted discovery without multiplexing limitations.[2]

What critics are saying

  • Olink's Explore HT delivers 6000+ proteins, capturing larger pharma budgets.[1]
  • SomaScan's 11,000-protein aptamer technology erodes biomarker discovery market share.[1]
  • Post-Series B cash burn exceeds revenue as manufacturing scales in 2026.[1]

What makes Nomic unique

  • nELISA technology enables 1000-plex protein measurement at $50 per sample affordably.[5]
  • DNA-barcoded beads decode protein identity on standard flow cytometers seamlessly.[3]
  • End-to-end service model compatible with existing lab workflows and automation.[4]

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

4%

2 year growth

1%
Yahoo Finance
Sep 19th, 2024
Nomic® Secures $42M in Oversubscribed Series B to Expand Access to Protein Profiling

MONTREAL, September 17, 2024--Nomic Bio ("Nomic"), the Protein Profiling company, today announces the completion of an oversubscribed $42 million Series B funding round. The fresh capital will enable Nomic to accelerate the expansion of its commercial operations, further invest in advancing its state-of-the-art protein profiling platform, and broaden its transformative offerings to meet growing demand.

BetaKit
Mar 18th, 2020
11 Canadian companies in Y Combinator’s Winter 2020 Demo Day

This week, Y Combinator (YC) held its Winter 2020 Demo Day, the 30th for the Silicon Valley incubator. To minimize health concerns during the COVID-19 outbreak, YC opted to host the demo day online. For this cohort, 16 Canadian startups participated.

TechCrunch
Mar 17th, 2020
All the companies from Y Combinator’s W20 Demo Day, Part IV: Healthcare, Biotech, Fintech and Nonprofits

Y Combinator’s Demo Day was a bit different this time around.

INACTIVE